COLLABORATION AGREEMENTCollaboration Agreement • March 18th, 2019 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 18th, 2019 Company Industry JurisdictionThis Collaboration Agreement (the “Agreement”) is made effective as of January 22, 2019 (the “Effective Date”), by and between Adimab, LLC, a Delaware limited liability company having an address at 7 Lucent Drive, Lebanon, NH 03766 (“Adimab”), and Checkpoint Therapeutics, Inc., having an address at 2 Gansevoort Street, 9th Floor, New York, NY 10014 (“Checkpoint”).